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Objective - To evaluate the early outcome of mitral
valve prostheses implantation and left ventricular remo-
deling in 23 patients with end-stage cardiomyopathy and
secondary mitral regurgitation (NYHA class III and IV).
Methods - Mitral valvular prosthesis implantation
with preservation of papillary muscles and chordae tendi-
nae, and plasty of anteriun cuspid for remodeling of the
left ventricle.
Results - The surgery was performed in 23 patients,
preoperative ejection fraction (echocardiography) varied
from 13% to 44% (median: 30%). In 13 patients associated
procedures were performed: myocardial revascularization
(9), left ventricle plicature repair (3) and aortic prosthese
implantation (1). Early deaths (2) occurred on the 4th PO
day (cardiogenic shock) and on the 20th PO day (upper
gastrointestinal bleeding), and a late death in the second
month PO (ventricular arrhythmia). Improvement occurred
in NYHA class in 82.6% of the patients (P<0.0001), with a
survival rate of 86.9% (mean of 8.9 months of follow-up).
Conclusion - This technique offers a promising thera-
peutic alternative for the treatment of patients in refrac-
tory heart failure with cardiomyopathy and secondary mi-
tral regurgitation.
Key words: mitral insufficiency, dilated cardiomyopathy,
mitral implantation.
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Heart failure has high incidence and prevalence 1 rates.
Because statistics are not available in Brazil, North Ameri-
can data 2 are being used,  which report that 400,000 new ca-
ses of heart failure are diagnosed annually. In spite of ade-
quate drug administration, only 50% of these patients have
a 5-year survival rate 3. Forty percent of patients in functio-
nal class IV (NYHA), have a one-year survival rate 3.
It is known that the treatment of choice for patients
with congestive heart failure refractory to medical treat-
ment, is heart transplantation. However, due to the reduced
number of donors, indication for this procedure is restricted.
Elderly patients, presence of other associated diseases, and
an inadequate socio-economic environment, are some of the
main factors that limit the use of transplantation, which is
considered the gold standard 1. In this set of patients short-
term outcome is not satisfactory having high mortality rates,
because currently no effective surgical alternative to heart
transplantation is available.
To comply with the above-mentioned restrictions to
heart transplantation, and in the attempt to benefit a large
number of patients, others surgical procedures have been
suggested, mainly: cardiomyoplasty 4-7, partial left ven-
triculotomy 8-11, mitral valve correction 12-14 and myocardial
revascularization itself 15.
Mitral insufficiency is one of the factors causing severe
hemodynamic changes in end-stage dilated cardiomyopathy.
In addition to worsening of functional class, a higher number
of hospital admissions, and a greater quantity of drugs
administered to ameliorate symptoms, mitral regurgitation is
also associated with a shorter survival of these patients 16-19.
Mitral regurgitation appears late in advanced dilated
cardiomyopathy and is caused by the interaction of the fol-
lowing factors: presence of segmentary alterations of  ven-
tricular contractility 20 papillary muscle disfunction 19, dila-
tion of the mitral valve ring 16,17,21, and, in particularly, geo-
metric alteration of the ventricular cavity 18, which changes
from an elliptic to as spherical shape, further deteriorating
ventricular performance.
Reviewing our series of patients who underwent par-
tial left venrticulotomy, as well as reports in the literature 9,
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we noticed that significant improvement occured in functio-
nal class, mainly in those patients who also underwent correc-
tion of mitral regurgitation. Based on these results, we deci-
ded to study, in patients with severe dilated cardiomyopathy
the impact of mitral prosthesis implantation associated with
procedures that determine remodeling of the left ventricle,
through shortening of the left ventricle longitudinal axis.
Methods
Twenty-three patients with dilated cardiomyophathy
and moderate to severe mitral regurgitation underwent to
this surgical procedure between December 1995 and De-
cember 1998. The cohort comprised 10 female and 13 male
patients from 25 to 78 years of age (55±24). Sixteen patients
were in NYHA class IV (72.7%) and 6 patients were in
NYHA class III (27.3%). In spite of having received ade-
quate and full medication, all patients had more than three
hospital admissions in the prior 6 months. Six patients were
in the intensive care unit dependent on inotropic support,
and four were on an intraaortic counterpulsation balloon.
Seven patients (30.4%) had undergone previous heart sur-
gery (five for myocardial revascularization, one for mitral
valve repair and one for partial left ventriculectomy). The
preoperative ejection fraction (measured by transthoracic
echocardiography) ranged from 13 to 44% (mean 30%) [fig.
1 (ventriculography)].
Regarding the causes of dilated cardiomyopathy, we
observed that 11 cases (47.8%) due to ischemia; 6 (26%) we-
re  idiopathic or not diagnosed; 3 (13%) had valvular cau-
ses; 1 (4.3%) gestational, 1 (4.3%) viral and 1 (4.3%) was due
to Chagas disease. Patient’s clinical characteristics are de-
tailed in table I.
Surgery was carried out in the usual way, by median
sternotomy, with cannulation of the aorta and both vena
cava. The mitral valve was approached through left longitu-
dinal atriotomy. The prosthesis implantation preserved the
valvular leaflets as well as the subvalvular system. The an-
terior leaflet was sectioned in the middle, its two margins
being sutured separately at the leved of the anterior com-
Fig. 1 - Left ventriculogram (OAD) in one of the patients showing left ventricle in
systole and mitral regurgitation.
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Table I – Distribution according to age, gender, cause, mitral insufficiency and evolution of functional classes
N Age Cause Etiology Insufficiency Functional Functional Functional Months
Mitral ECO Class Pre Class Class actual of follow-up
1 68 M Isc M/S III II 39
2 72 M I S IV II II 19
3 25 F P S IV II II 18
4 54 M I M/S III II II 15
5 36 M I S IV II/III II/III 15
6 58 M I S IV II II 15
7 75 F Isc M IV Death Death 4º d PO
8 68 M Isc M III II II 11
9 60 F Isc M IV II II 11
10 50 F I S III II IV 10
11 78 F Isc M III II 9
12 37 M Isc S IV II III 9
13 38 M Viral S IV III II/III 9
14 63 M I S IV Death Death 20º d PO
15 40 F I S IV Death Death 2º m PO
16 47 F I S IV II II 7
17 52 M Isc S IV IV/III II 7
18 49 F I S III II II 7
19 61 M Isc S IV II II 7
20 60 F Chagas S III/IV II II 6
21 69 M Isc S IV II/III II 6
22 72 F I S III/IV II 5
23 57 M Isc S IV III II 3
Me 55,28
SE 12,80
Isc- ischemic; I- idiopatic; P- peripheral; M- moderate; S- severe.
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missure and the other in the posterior comissure (fig. 2).
This maneuver determines the shortening of the longitudi-
nal axis of the left ventricle, in an equivalent distance
between the free border of the cuspid and its insertion in the
left atrioventricular ring. By traction of the base of the pap-
pillary muscle, we try to restore the ovoid shape of the left
ventricle, which in conditions of end-stage cardiomyopha-
thy tends to be spherical.
In most of the cases (85%), the prostheses used were
biological with external diameters varying from 27 to 33mm.
The procedure was carried out after approval of the institu-
tion and patients.
Based on the cause that led to the terminal cardiomyo-
pathy, complementary surgical procedures were carried out,
namely, myocardial revascularization with bypass (8 cases),
and plicature of nonkinetic areas of the left ventricle (2 ca-
ses). None of these complementary procedures was, at preo-
perative assessment, of sufficient importance to justify re-
fractory heart failure or surgery itself. They were carried out
as coadjuvants to the main indication.
By defintion, mitral regurgitation was not the cause
of cardiomyopathy, but the consequence of it due to
dilation of the mitral ring and the spherical shape of the left
ventricle.
Only patients with moderate or severe mitral regurgita-
tion evaluated by transesophageal echocardiography were
considered for the procedure. They included patients with
either significant regurgitation near the pulmonary veins or
high “V” wave values of the pulmonary capillary pressure,
or both.
The conventional transthoracic echocardiography
and the left ventriculography carried out in the catheteri-
zation laboratory are not reliable because they underesti-
mate the importance of mitral regurgitation in very low ejec-
tion fractions. Furthermore ejection fraction is overestima-
ted due to lower afterload (mitral regurgitation).
All patients were followed up during the hospital stay
and postoperative period by a member of the surgical team
and a pre- and postoperative data comparison protocol was
carried out, analysing clinical outcome and echocardiogra-
phic findings.
Our central hypothesis was based on the assumption
that clinical improvement would occur (using the patient’s
functional class as a parameter) correcting mitral regurgi-
tation. Echocardiographic findings were compared basical-
ly at three stages: preoperative, postoperative during hos-
pital stay before discharge and in the last evaluation. For
this, analysis of variance using Friedman’s test was carried
out (using multiple comparison tests) to compare distribu-
tions of the pre- and postoperative functional class and the
current class. The alpha error was established as P<0.01.
Results
We observed a significant improvement in functional
class in patients who underwent this procedure. At the last
follow-up 17 (85%) were in functional class II, 2 (10%) in FC
III and 1 (5%) in FC IV, even though no changes were made
in he use of medication, when compared with the preopera-
tive evaluation (fig. 3). The analysis of variance with Fried-
man’s test resulted in a chi-square value of 24.11, with
P<0.0001, showing that the functional class improved signi-
ficantly after surgery, and remained stable during follow-
up(multiple comparison tests, with P<0.01: preoperati-
ve>posteroperative = follow-up).
Regarding ventricular function, which was measured
by echocardiography, carried out by the same surgical team,
it was observed that the ejection fraction that ranged betwe-
en 13 and 44% with a mean of 28% prior to the operation,
one month after ranged between 28 and 53% with a mean of
31%. Currently, the ejection fraction ranges between 10 and
60%, with a mean of 32% (fig. 4). Two patients merit special
mention because their postoperative evolution substantia-
tes the thesis advocated in this paper. Two months after the
operation in one case and 3 months in the other, a severe
worsening in functional class took place and was attributed
to a considerable perivalvular leak. Its surgical repair, once
again allowed restoration to functional class II.
Fig. 2 - Technique of mitral prosthesis implantation preserving papillary muscles. The
reduction in left ventricular longitudinal axis is equivalent to the distance between
the leaflet free margin and the mitral annulus. Fig. 3 - Functional classes pre, post (1st month) and present.
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Due to critical clinical conditions, intravenous vasoac-
tive drugs were used in 6 patients and mechanical circulatory
support (intraaortic counterpulsation balloon) was used in
another before surgery. Of these, two had satisfactory
postoperative evolution, and were in functional class II in the
respective postoperative follow-up of 18 and 7 months.
With regard to valve disfunction during all surgical pro-
cedures, we observed that the valve escape was related to an
inadequate coaptation of the valvular leaflets as well as to the
dilatation of the mitral ring. In 13 patients, associated opera-
tions were performed (myocardial revascularization in 9
patients ventricular aneurysm plicature repair in 3) and aortic
prosthesis (1).
Bypass time ranged from 60 to 123min (mean 95min),
and aortic clamping, varied from 0 to 80min (mean of 43min).
Antegrade blood cardioplegic solution was used in 17 pati-
ents, and in 6 patients, no clamping was used. Only one pa-
tient needed intraaortic ballon counterpulsation after car-
diopulmonary bypass.
During the evolution of the patients in the intensive
care unit (ICU), we observed that six patients required va-
soactive drugs for a period of over 72 hours, of which four
were (3,7,9 and 15 months after the operation) in FC II and
two (7and 15 months after the operation) were in FC III.
Two early deaths occurred [2/23 (8.7%)]; one late
death [1/21 (4,8%)] occurred at the two month follow-up.
The cause was low cardiac output on the 4th postoperative
day in one patient, and upper digestive tract hemorrhage
on the 20th day in another who had significant concurrent
diseases and had had a previous partial ventriculectomy 6
months earlier.  The late death on the 60th postoperative day
occurred in a patient with dilated cardiomyopathy who had
satisfatory immediate evolution and had ventricular fibrilla-
tion during the emergency admission.
Four patients were re-admitted with heart failure, two
undergoing the new surgical approach because of perival-
vular leak, one patient due to bradyarrhythmia and another
because of myocardial failure.
The postoperative evolution of functional class,
ejection fraction, and ventricular diameters may be seen in
tables I and II and figures 4 and 5. The actuarial survival cur-
ve is shown in figure 6. The follow-up times (in months) of
each patient are reported in table I.
Discussion
Others than transplant surgerys selected for end-stage
dilated cardiomyopathy 4,8,9,11 refractory to conventional
medical treatment have not meet the expectations of improved
performance in ventricular function. Most of the patients
have not exhibited improved short-term survival rates or ade-
quate quality of life 7,9,11,15. All these surgeries have thoroug-
hly reported shortcomings, such as high mortality rates in
patients who undergo partial left ventriculectomy 9-11, me-
dium-term failure of the graft due to fatty degeneration of the
skeletal fibers in cardiomyoplasty 6,7 and imcomplete reso-
lution of heart failure with myocardial revascularization 15.
Considering the positive results reported in the literature 12-14
concerning mitral valve reconstruction, the technique descri-
Fig. 4 - Ejection fraction before surgery, during first month, and at last evaluation.
 Fig. 6 - Actuarial survival curve of the 23 patients showing a stable life expectancy
after the immediate risk of surgery.
Fig. 5 - Comparison of diameters (systolic and diastolic) of left ventricle in three
phases showing insignificant reduction in left ventricular chamber.
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bed in this paper is different because it causes reduction in
the longitudinal axis of the left ventricle bringing the top of
the papillary muscles near the left atrioventricular annulus in
an amount that is equivalent of the distance between the free
magin of the mitral leaflets and the mitral annulus.
The physiopatlology of the dilated cardiomyopathy
gradually leads to a change in the geometry of the left ven-
tricular cavity. Originally with an elliptical shape, it gradual-
ly becomes spherical 18. Dilation of the mitral ring21 and impa-
irment of the papillary muscles 19 also occur, which cause
segmentary alterations in ventricular contractility 20, deter-
mine noncoaptation of the valvular leaflets with subse-
quent valve escape. This is a factor obviously associated
with clinical and hemodynamic worsening, as well as with a
poor short-term prognosis 22.
In this situation, the left ventricle begins to work with
higher volume and pressure levels. Thus, tension in the wall in-
creases in a ventricle that has already undergone  chronic ag-
gression. The outcome is a worsening of ventricular contrac-
tion. Batista et al. 8,10 precisely propose reducing the diameter of
the ventricle and consequently diminishing wall tension.
When we suggested implantation of a prosthesis in
the mitral position, keeping all valve structures through
displacement of the anterior leaflet together with preser-
vation of the posterior leaflet 24, we aimed to stop the valve
regurgitation and to remodel the ventricular cavity with the
shortening of its longitudinal axis. We also mantained that
the contracting function of the papillary muscles and the
wall tension is reduced without the need of ventricular re-
section. We believe that this technique adds a benefit to the
performance of the left ventricle more than just simply cor-
recting the mitral regurgitation through reconstruction.
This proposition to implant a prosthesis for the correc-
tion of mitral regurgitation, contrary to what was previously be-
lieved, causes improvement in cardiac output despite the same
ejection fraction because it eliminates regurgitant flow with the
totality of volumetric reduction used in ventricular systole.
Clinical and experimental studies have shown that preser-
vation of the leaflets as well as of the subvalvular structures is
beneficial to ventricular function 25, mainly in patients with se-
vere heart failure. It is known that the mitral valve system is an
integral part of the electromechanical mechanism of ventricular
systole, although the mechanisms through which function of
the mitral valve system changes and the geometry of the left
ventricle is altered remain unknown.
By implanting a prosthesis, we were able maintain the
entire valvular system with its leaflets, chordae tendinae
and papillary muscles, as well as carry out reconstruction of
the anterior leaflet, determine a remodeling of the left ven-
tricle with enhanced ventricle performance, all of which re-
sulted in clinical improvement, a fact observed in the cohort
studied. The theoretical inconvenience of a prosthesis im-
plantation is irrelevant if we consider that its life span will
probably be greater than the patient’s survival.
As limitation of our experience we admit is that the as-
sociated procedures carried out in 13 cases might influence
Table II – Ejection fraction (transthoracic echocardiography) pre, 1 month, present and diastolic-systolic volumes of left vent ricle.
N0 Ejection Ejection Ejection DDLV/SDLV DDLV/SDLV DDLV/SDLV
fraction fraction fraction pre  post present
pre(%) I month present (%)
1 - - -
2 44 47 43 (16º m PO) 61/44 60/49 60/47
3 43 32 45 (15º m PO) 68/49 60/46 60/46
4 35 35 39 (12º m PO) 60/42 58/40 57/39
5 28 42 28 (8º m PO) 104/90 98/86 95/89
6 32 28 88/80 72/59
7 35 Death PO 42/26 -
8 39 64 60 (8º m PO) 62/46 64/45 63/42
9 15 25 29 (6º m PO) 59/42 - 54/49
10 35 25 10 (6º m PO) - 88/80 92/82
11 - 53 - 45/32
12 20 28 28 (2º m PO) 63/50 60/48 71/64
13 19 31 24 (2º m PO) 73/63 68/58 80/70
14 15 Death 69/59 -
15 23 28 80/73 74/68
16 42 Late death 42 (2º m PO) 72/60 68/56
17 36 36 36 (4º m PO) 65/56 - 67/56
18 28 23 45 (6º m PO) 80/69 74/68 60/46
19 30 34 34 (3º m PO) 88/77 - 78/65
20 13 15 20 (1º m PO) 64/54 65/55 65/55
21 32 31 28 (pós-alta) 65/55 62/55 62/53
22 15 20 20 (1º m PO) 63/52 61/42 61/42
23 19 19 70/59 64/55
Med 28 32 33 70/57 67/55 68/56
DP 10 12 12 13/15 12/14 13/15
DDLV- diastolic diameter of left ventricle; SDLV- systolic diameter of left ventricle; PO- postoperative.
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and perhaps overestimate the benefit of the procedure; ho-
wever we point out, that none of these additional surgical
procedures were the sole indication for surgery.
 Despite the lack of records on long-term evolution, the
surgical technique described in this paper is attractive, be-
cause the results obtained showed a survival rate of 86.9%
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in the period under observation. We conclude that surgery
was beneficial for 82.6% of the patients in the period of fol-
low-up and resulted in a significant improvement in functio-
nal classes. Our data suggest that this technique may be a
possible alternative for the treatment of severe cardiomyo-
pathy with mitral regurgitation.
